Aptinyx reports Q4 results - Mcdonough GA Apartments For Rent That You Can Easily Afford
15744
post-template-default,single,single-post,postid-15744,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-theme-ver-11.0,qode-theme-bridge,wpb-js-composer js-comp-ver-5.1.1,vc_responsive
 

Aptinyx reports Q4 results

Aptinyx reports Q4 results

Net Loss: ($14.1M) (-95.8%); Loss Per Share: ($0.42) (+69.1%); Quick Assets: $150.6M (+63.5%).

The Company initiated Phase 2a study of NYX-783 in patients with PTSD, data expected in 1H 2020.

Also, Aptinyx is nearing completion of Phase 1 study of NYX-458 in healthy volunteers with data expected in 1H 2019.

Previously: Aptinyx beats by $0.08, misses on revenue (March 21)

Source Article